logo
16:01 Mar 06

Gennex Laboratories Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
10.99
-0.23 (-2.05%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Gennex Laboratories Ltd. Financials

Gennex Laboratories Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
10.99
-0.23 (-2.05%)
16:01 Mar 06
Quality
image/svg+xml

55/100
High Financial Strength

Valuation
image/svg+xml

44/100
Mid Valuation

Technical

34/100
Technically Bearish

Strength

9

Weakness

5

Opportunity

0

Threats

0

9.70 %

ROE %

7.07 %

ROA %

0.00

EPS

8.21

BVPS

13.14 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
61.21 65.6 86.71 137.9 152.12
Operating Expenses +
55.83 60.91 69.68 121.19 133.72
Raw Material
40.01 46.91 57.88 100.59 117.4
Increase Decrease in Cost
-1.91 -7 -9.03 -3.51 -9.19
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
6.97 7.87 7.79 8.35 8.95
Miscellaneous Expenses
10.76 13.13 13.04 15.76 16.56
Operating Profit
5.38 4.69 17.03 16.71 18.4
Other Income
1.38 3.95 4.91 10.43 10.76
Depreciation
0.79 0.92 2.37 1.99 2.02
Interest
0.88 1.35 3.08 3.61 4.32
Profit before tax and exceptio..
5.09 6.37 16.49 21.55 22.82
Exceptional Items
0 0 0 -0.15 -0.3
PBT
5.09 6.37 16.49 21.4 23.12
Provision for Taxation
1.17 1.45 3.32 3.27 2.93
Net Profit
3.92 4.92 13.18 18.12 19.59
NET Profit after MI
3.92 4.92 13.18 18.12 22.95
EPS
0.33 0.42 0.66 0.78 0.79
Operating Profit Margin (%)
8.79 7.15 19.64 12.12 12.1
Net Profit Margin (%)
6.4 7.5 15.2 13.14 15.09

Gennex Laboratories Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Promoter 23.60 23.60 19.80 18.40 18.40 18.40
FII 0.00 0.00 0.00 0.00 0.00 0.00
Public 0.00 0.00 0.00 0.00 0.00 0.00
Others 76.40 76.40 80.20 81.60 81.60 81.60
Shareholder Shares Holding %
Research 360 logo
Download Our App On: